Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligometastatic ES-SCLC
Abroad (travel likely)RecruitingPHASE2
Conditions
Extensive-stage Small-cell Lung Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University Hospital Augsburg, Radiation Oncology, Augsburg, Bavaria, Germany
University Hospital Erlangen, Radiation Oncology, Erlangen, Bavaria, Germany
University Hospital Regensburg, Clinic and Polyclinic for Radiotherapy, Regensburg, Bavaria, Germany
Kliniken Maria Hilf, Mönchengladbach, North Rhine-Westphalia, Germany
Saarland University Medical Center and Saarland University Faculty of Medicine, Clinic for Radiotherapy and Radiooncology, Homburg, Saarland, Germany